Noetzel E - Search Results

1

Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.

Noetzel E, Rose M, Bornemann J, Gajewski M, Knüchel R, Dahl E. Noetzel E, et al. Oncogene. 2012 Apr 19;31(16):2101-14. doi: 10.1038/onc.2011.403. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909132

2

Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.

Veeck J, Geisler C, Noetzel E, Alkaya S, Hartmann A, Knüchel R, Dahl E. Veeck J, et al. Among authors: noetzel e. Carcinogenesis. 2008 May;29(5):991-8. doi: 10.1093/carcin/bgn076. Epub 2008 Mar 19. Carcinogenesis. 2008. PMID: 18356147

3

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knüchel R, Dahl E. Noetzel E, et al. BMC Cancer. 2008 May 30;8:154. doi: 10.1186/1471-2407-8-154. BMC Cancer. 2008. PMID: 18513385 Free PMC article.

4

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.

Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel R, Fasching PA, Dahl E. Bektas N, et al. Among authors: noetzel e. Breast Cancer Res. 2008;10(4):R58. doi: 10.1186/bcr2117. Epub 2008 Jul 15. Breast Cancer Res. 2008. PMID: 18627608 Free PMC article.

5

[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].

Noetzel E, Veeck J, Horn F, Hartmann A, Knüchel R, Dahl E. Noetzel E, et al. Pathologe. 2008 Nov;29 Suppl 2:319-27. doi: 10.1007/s00292-008-1038-7. Pathologe. 2008. PMID: 18807039 German.

6

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E. Veeck J, et al. Among authors: noetzel e. Mol Cancer. 2008 Nov 6;7:83. doi: 10.1186/1476-4598-7-83. Mol Cancer. 2008. PMID: 18990230 Free PMC article.

7

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Verjans E, Noetzel E, Bektas N, Schütz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J. Verjans E, et al. Among authors: noetzel e. BMC Cancer. 2009 Jul 14;9:230. doi: 10.1186/1471-2407-9-230. BMC Cancer. 2009. PMID: 19602265 Free PMC article.

8

Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.

Noetzel E, Rose M, Sevinc E, Hilgers RD, Hartmann A, Naami A, Knüchel R, Dahl E. Noetzel E, et al. Oncogene. 2010 Aug 26;29(34):4814-25. doi: 10.1038/onc.2010.229. Epub 2010 Jun 14. Oncogene. 2010. PMID: 20543860

9

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.

Serce NB, Boesl A, Klaman I, von Serényi S, Noetzel E, Press MF, Dimmler A, Hartmann A, Sehouli J, Knuechel R, Beckmann MW, Fasching PA, Dahl E. Serce NB, et al. Among authors: noetzel e. BMC Cancer. 2012 Dec 13;12:597. doi: 10.1186/1471-2407-12-597. BMC Cancer. 2012. PMID: 23236990 Free PMC article.

10

Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.

Schlensog M, Magnus L, Heide T, Eschenbruch J, Steib F, Tator M, Kloten V, Rose M, Noetzel E, Gaisa NT, Knüchel R, Dahl E. Schlensog M, et al. Among authors: noetzel e. Epigenetics. 2018;13(3):214-227. doi: 10.1080/15592294.2016.1229730. Epub 2018 Apr 18. Epigenetics. 2018. PMID: 27623992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters